Table 2.
Survey Respondent’s Experience with Medicinal Cannabis for IBD Management in Their Current Patient Cohorts
| Response | N | ^Valid % | |
|---|---|---|---|
| I have patients who currently use MC for IBD | Yes | 36 | 39.1 |
| No | 56 | 60.9 | |
| Number of patients using MC# | 1–3 patients | 18 | 66.7 |
| 4–6 patients | 6 | 22.2 | |
| ≥ 10 patients | 3 | 11.1 | |
| How is MC being used by patients? | Adjunct to conventional treatments | 32 | 84.2 |
| In place of conventional treatments | 4 | 10.5 | |
| Unsure | 2 | 5.3 | |
| Enquiries about MC in past 3 months | None | 33 | 41.8 |
| (% of your total IBD patient cohort) | 1%–9% | 36 | 45.6 |
| 10%–24% | 10 | 12.6 |
MC, medicinal cannabis; IBD, inflammatory bowel disease.
^Valid % refers to the percentage of the total number of responses for that survey item.
# N = 27 responses for this item only.